Theodore A. Bass, M.D.

Theodore A. Bass M.D.

Professor

Department: Department of Medicine
Business Phone: (904) 244-2655
Business Email: theodore.bass@jax.ufl.edu
Appointments and Locations

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease
  • Interventional Cardiology

Clinical Profile

Specialties
  • Cardiovascular Disease
  • Interventional Cardiology
Interests
  • Clinical Special Interests: Coronary artery disease; interventional cardiology

Publications

2023
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.
JACC. Cardiovascular interventions.16(10):1239-1291[DOI] 10.1016/j.jcin.2023.04.011.[PMID] 37115166.
PubMed·Publisher's Site
2023
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.
Journal of the American College of Cardiology.81(14):1386-1438[DOI] 10.1016/j.jacc.2022.11.002.[PMID] 36801119.
PubMed·Publisher's Site
2023
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.
Circulation. Cardiovascular interventions.16(4):e000088-[DOI] 10.1161/HCV.0000000000000088.[PMID] 36795800.
PubMed·Publisher's Site
2022
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease.
European heart journal. Cardiovascular pharmacotherapy.8(5):452-461[DOI] 10.1093/ehjcvp/pvab042.[PMID] 34114623.
2 citations·PubMed·Publisher's Site
2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
Thrombosis and haemostasis.122(8):1341-1351[DOI] 10.1055/a-1730-8725.[PMID] 34983074.
2 citations·PubMed·Publisher's Site
2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
European heart journal. Cardiovascular pharmacotherapy.8(7):728-737[DOI] 10.1093/ehjcvp/pvac022.[PMID] 35353154.
2 citations·PubMed·Publisher's Site
2021
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor.
JACC. Cardiovascular interventions.14(21):2410-2412[DOI] 10.1016/j.jcin.2021.07.051.[PMID] 34736741.
2 citations·PubMed·Publisher's Site
2020
Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
Thrombosis and haemostasis.120(1):83-93[DOI] 10.1055/s-0039-1695772.[PMID] 31470444.
17 citations·PubMed·Publisher's Site
2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.
Circulation.142(15):1500-1502[DOI] 10.1161/CIRCULATIONAHA.120.048770.[PMID] 33044856.
10 citations·PubMed·Publisher's Site
2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.
Journal of the American Heart Association.9(8):e015865-[DOI] 10.1161/JAHA.120.015865.[PMID] 32306797.
16 citations·PubMed·Publisher's Site
2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.
JACC. Basic to translational science.5(5):419-428[DOI] 10.1016/j.jacbts.2020.02.009.[PMID] 32478205.
17 citations·PubMed·Publisher's Site
2019
Clinical Conference Proceedings: 15th Biennial International Andreas Gruentzig Society Meeting.
The Journal of invasive cardiology.31(6):E98-E132[DOI] .[PMID] 31158808.
PubMed·Publisher's Site
2019
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.
JACC. Cardiovascular interventions.12(16):1538-1549[DOI] 10.1016/j.jcin.2019.05.028.[PMID] 31377269.
23 citations·PubMed·Publisher's Site
2019
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.
JACC. Basic to translational science.4(7):763-775[DOI] 10.1016/j.jacbts.2019.07.011.[PMID] 31998847.
12 citations·PubMed·Publisher's Site
2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Circulation.139(14):1661-1670[DOI] 10.1161/CIRCULATIONAHA.118.038317.[PMID] 30630341.
82 citations·PubMed·Publisher's Site
2018
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Circulation.137(23):2450-2462[DOI] 10.1161/CIRCULATIONAHA.118.033983.[PMID] 29526833.
43 citations·PubMed·Publisher's Site
2017
Challenges for Expanded Use of Transcatheter Aortic Valve Replacement.
Circulation. Cardiovascular interventions.10(12):-[DOI] 10.1161/CIRCINTERVENTIONS.117.006208.[PMID] 29246922.
1 citations·PubMed·Publisher's Site
2017
Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus.
Thrombosis and haemostasis.117(1):201-203[DOI] 10.1160/TH16-08-0594.[PMID] 27786340.
6 citations·PubMed·Publisher's Site
2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Ticagrelor-Treated Patients.
JACC. Cardiovascular interventions.10(13):1374-1375[DOI] 10.1016/j.jcin.2017.04.027.[PMID] 28683943.
8 citations·PubMed·Publisher's Site
2017
Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase.
Circulation.135(15):1385-1387[DOI] 10.1161/CIRCULATIONAHA.116.022151.[PMID] 28396376.
3 citations·PubMed·Publisher's Site
2017
Percutaneous Interventional Repair of an Intraoperative Right Coronary Artery Tear.
JACC. Cardiovascular interventions.10(23):2464-2465[DOI] 10.1016/j.jcin.2017.07.039.[PMID] 29153495.
PubMed·Publisher's Site
2017
Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case series.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.90(1):104-111[DOI] 10.1002/ccd.26775.[PMID] 27566914.
7 citations·PubMed·Publisher's Site
2017
The Challenges Involving Assessing Percutaneous Coronary Intervention Outcomes in Safety-Net Hospitals.
JACC. Cardiovascular interventions.10(15):1486-1488[DOI] 10.1016/j.jcin.2017.06.019.[PMID] 28797423.
PubMed·Publisher's Site
2016
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
European heart journal.37(35):2722-30[DOI] 10.1093/eurheartj/ehv744.[PMID] 26848148.
49 citations·PubMed·Publisher's Site
2016
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Cell transplantation.25(9):1701-1711[DOI] .[PMID] 27151378.
43 citations·PubMed·Publisher's Site
2016
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
Journal of the American College of Cardiology.67(17):1994-2004[DOI] 10.1016/j.jacc.2016.02.045.[PMID] 27012781.
88 citations·PubMed·Publisher's Site
2016
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Thrombosis and haemostasis.115(3):622-31[DOI] 10.1160/TH15-06-0467.[PMID] 26633836.
21 citations·PubMed·Publisher's Site
2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors.
Thrombosis and haemostasis.116(6):1060-1069[DOI] .[PMID] 27488362.
7 citations·PubMed·Publisher's Site
2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Circulation.134(11):780-92[DOI] 10.1161/CIRCULATIONAHA.116.023402.[PMID] 27559041.
74 citations·PubMed·Publisher's Site
2016
Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.
JACC. Cardiovascular interventions.9(11):1089-98[DOI] 10.1016/j.jcin.2016.02.039.[PMID] 27013060.
31 citations·PubMed·Publisher's Site
2016
Revascularization of Unprotected Left Main Coronary Artery Disease: Implications of Evolving Data on Clinical Practice.
Circulation. Cardiovascular interventions.9(12):-[DOI] .[PMID] 27941059.
3 citations·PubMed·Publisher's Site
2016
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
JACC. Cardiovascular interventions.9(15):1576-85[DOI] 10.1016/j.jcin.2016.05.003.[PMID] 27491607.
89 citations·PubMed·Publisher's Site
2015
High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges.
Circulation. Cardiovascular interventions.8(12):e003405-[DOI] 10.1161/CIRCINTERVENTIONS.115.003405.[PMID] 26628592.
14 citations·PubMed·Publisher's Site
2015
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.
JACC. Cardiovascular interventions.8(11):1457-1467[DOI] 10.1016/j.jcin.2015.02.030.[PMID] 26404199.
66 citations·PubMed·Publisher's Site
2015
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation.
JACC. Cardiovascular interventions.8(8):1075-1083[DOI] 10.1016/j.jcin.2015.02.022.[PMID] 26117466.
4 citations·PubMed·Publisher's Site
2015
Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention.
Journal of the American College of Cardiology.65(16):1714-1715[DOI] 10.1016/j.jacc.2014.12.069.[PMID] 25908082.
PubMed·Publisher's Site
2014
Appropriate use criteria for cardiac catheterization and coronary revascularization.
Chinese medical journal.127(6):1161-5[DOI] .[PMID] 24622451.
2 citations·PubMed·Publisher's Site
2014
Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.
Journal of cardiovascular translational research.7(1):53-63[DOI] 10.1007/s12265-013-9535-3.[PMID] 24395495.
21 citations·PubMed·Publisher's Site
2014
Impact of academic year timing on percutaneous coronary intervention outcomes at training institutions.
Journal of the American College of Cardiology.63(10):1025-6[DOI] 10.1016/j.jacc.2013.11.019.[PMID] 24333492.
1 citations·PubMed·Publisher's Site
2014
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease.
Journal of cardiovascular translational research.7(1):47-52[DOI] 10.1007/s12265-013-9530-8.[PMID] 24357254.
6 citations·PubMed·Publisher's Site
2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
Journal of the American College of Cardiology.64(10):1005-14[DOI] 10.1016/j.jacc.2014.06.1170.[PMID] 25190236.
131 citations·PubMed·Publisher's Site
2014
Interventional Cardiology US Workforce: current challenges.
Circulation. Cardiovascular interventions.7(6):733-5[DOI] 10.1161/CIRCINTERVENTIONS.114.002136.[PMID] 25516756.
2 citations·PubMed·Publisher's Site
2014
Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluation.
JACC. Cardiovascular interventions.7(7):810-6[DOI] 10.1016/j.jcin.2013.11.026.[PMID] 24954573.
30 citations·PubMed·Publisher's Site
2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.
JACC. Cardiovascular interventions.7(4):426-34[DOI] 10.1016/j.jcin.2013.11.019.[PMID] 24630878.
27 citations·PubMed·Publisher's Site
2014
Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.
Thrombosis and haemostasis.111(2):258-65[DOI] 10.1160/TH13-07-0529.[PMID] 24154863.
10 citations·PubMed·Publisher's Site
2014
Quality initiatives in the cardiac catheterization and interventional laboratories.
Chinese medical journal.127(6):1155-60[DOI] .[PMID] 24622450.
3 citations·PubMed·Publisher's Site
2014
Roadmap to quality and innovation.
Chinese medical journal.127(6):1197-8[DOI] .[PMID] 24622464.
PubMed·Publisher's Site
2013
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures).
Journal of the American College of Cardiology.62(4):357-96[DOI] 10.1016/j.jacc.2013.05.002.[PMID] 23665367.
103 citations·PubMed·Publisher's Site
2013
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures).
Circulation.128(4):436-72[DOI] 10.1161/CIR.0b013e318299cd8a.[PMID] 23658439.
52 citations·PubMed·Publisher's Site
2013
ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures).
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.82(2):E69-111[DOI] 10.1002/ccd.24985.[PMID] 23653399.
25 citations·PubMed·Publisher's Site
2013
Candidates for transcatheter aortic valve replacement: fitting the PARTNERS criteria.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.82(4):655-61[DOI] 10.1002/ccd.24706.[PMID] 23074160.
4 citations·PubMed·Publisher's Site
2013
Conversation in cardiology: should FFR and IVUS be counted as PCI?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.82(1):110-5[DOI] 10.1002/ccd.24854.[PMID] 23404738.
PubMed·Publisher's Site
2013
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
Journal of thrombosis and thrombolysis.35(2):155-64[DOI] 10.1007/s11239-012-0846-z.[PMID] 23184484.
22 citations·PubMed·Publisher's Site
2013
Effects of Cangrelor in Prasugrel Treated Patients: a Pharmacodynamic in Vitro Investigation
Circulation.128(22, S):-[DOI] .[PMID] .
PubMed·Publisher's Site
2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation.
Thrombosis and haemostasis.110(4):777-84[DOI] 10.1160/TH13-05-0400.[PMID] 23884248.
6 citations·PubMed·Publisher's Site
2013
Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.
JACC. Cardiovascular interventions.6(2):182-4[DOI] 10.1016/j.jcin.2012.10.007.[PMID] 23428011.
10 citations·PubMed·Publisher's Site
2013
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus.
Journal of thrombosis and thrombolysis.36(1):14-7[DOI] 10.1007/s11239-012-0828-1.[PMID] 23143668.
13 citations·PubMed·Publisher's Site
2013
Impaired Responsiveness To Clopidogrel in Type 2 Diabetes: a Mechanistic Study
Circulation.128(22, S):-[DOI] .[PMID] .
PubMed·Publisher's Site
2013
Operator Radiation Exposure and Physical Discomfort During a Right Versus Left Radial Approach for Coronary Interventions: a Randomized Evaluation
Journal of the American College of Cardiology.61():E1683-[DOI] .[PMID] .
PubMed·Publisher's Site
2013
Percutaneous coronary interventions in ST-segment-elevation myocardial infarction: shifting paradigms and future perspectives.
Circulation. Cardiovascular interventions.6(6):593-5[DOI] 10.1161/CIRCINTERVENTIONS.113.001060.[PMID] 24347653.
PubMed·Publisher's Site
2013
Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof?
American heart journal.165(2):133-42[DOI] 10.1016/j.ahj.2012.10.017.[PMID] 23351815.
28 citations·PubMed·Publisher's Site
2012
Certification and competency in interventional cardiology: the changing landscape.
Circulation. Cardiovascular interventions.5(4):450-3[DOI] 10.1161/CIRCINTERVENTIONS.112.972844.[PMID] 22896572.
7 citations·PubMed·Publisher's Site
2012
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
JACC. Cardiovascular interventions.5(3):293-300[DOI] 10.1016/j.jcin.2011.09.027.[PMID] 22440495.
42 citations·PubMed·Publisher's Site
2012
Effects of Pioglitazone On Platelet P2Y12 Mediated Signaling in Clopidogrel Treated Patients With Type 2 Diabetes Mellitus
Journal of the American College of Cardiology.59():E263-[DOI] .[PMID] .
PubMed·Publisher's Site
2012
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.
Thrombosis and haemostasis.108(5):930-6[DOI] 10.1160/TH12-06-0397.[PMID] 22782352.
12 citations·PubMed·Publisher's Site
2012
Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study.
Journal of the American College of Cardiology.59(19):1681-7[DOI] 10.1016/j.jacc.2011.12.039.[PMID] 22554598.
15 citations·PubMed·Publisher's Site
2012
Radial Access: Is There An Increased Risk of Operator Radiation Exposure During a Right Versus Left Radial Approach?
Journal of the American College of Cardiology.60():B117-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study].
Revista espanola de cardiologia.64(7):557-63[DOI] 10.1016/j.recesp.2011.01.020.[PMID] 21641709.
4 citations·PubMed·Publisher's Site
2011
Assessment of Dynamic Coronary Plaque Changes and the Clinical Consequences in Type-II Diabetic Patients: a Serial Intracoronary Ultrasound Study
Revista Espanola De Cardiologia.64(7):557-563[DOI] 10.1016/j.rec.2011.01.018.[PMID] .
PubMed·Publisher's Site
2011
Candidates for Transcatheter Aortic Valve Replacement (Tavr): Fitting the Current Partners Criteria?
Journal of the American College of Cardiology.58():B197-B198[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Effects of Cangrelor On Platelet Function Profiles in Patients With Coronary Artery Disease: Results of An in Vitro Pharmacodynamic Investigation
Journal of the American College of Cardiology.57():E1634-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease.
Thrombosis and haemostasis.105(4):730-2[DOI] 10.1160/TH10-10-0652.[PMID] 21225097.
30 citations·PubMed·Publisher's Site
2011
Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease.
Thrombosis and haemostasis.106(1):67-74[DOI] 10.1160/TH10-12-0785.[PMID] 21655674.
35 citations·PubMed·Publisher's Site
2011
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
Thrombosis and haemostasis.106(2):253-62[DOI] 10.1160/TH11-01-0041.[PMID] 21614414.
33 citations·PubMed·Publisher's Site
2011
Impact of Cangrelor On Multiple Platelet Signaling Pathways in Patients With Coronary Artery Disease
Journal of the American College of Cardiology.57():E1931-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Impact of Concomitant and Staggered Pantoprazole Intake On Pharmacodynamic Effects Induced By Clopidogrel
Journal of the American College of Cardiology.57():E1907-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study.
Journal of the American College of Cardiology.58(13):1396-8[DOI] 10.1016/j.jacc.2011.06.031.[PMID] 21920272.
7 citations·PubMed·Publisher's Site
2011
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Journal of the American College of Cardiology.58(1):30-9[DOI] 10.1016/j.jacc.2011.02.040.[PMID] 21700086.
45 citations·PubMed·Publisher's Site
2011
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
JACC. Cardiovascular interventions.4(8):905-12[DOI] 10.1016/j.jcin.2011.05.016.[PMID] 21851906.
16 citations·PubMed·Publisher's Site
2011
Intramyocardial, autologous CD34+ cell therapy for refractory angina.
Circulation research.109(4):428-36[DOI] 10.1161/CIRCRESAHA.111.245993.[PMID] 21737787.
356 citations·PubMed·Publisher's Site
2011
Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.
Journal of the American College of Cardiology.58(14):1426-32[DOI] 10.1016/j.jacc.2011.07.005.[PMID] 21939824.
157 citations·PubMed·Publisher's Site
2011
Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
Journal of the American College of Cardiology.57():E1910-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Circulation. Cardiovascular interventions.4(2):180-7[DOI] 10.1161/CIRCINTERVENTIONS.110.960187.[PMID] 21386092.
151 citations·PubMed·Publisher's Site
2011
Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study.
Circulation. Cardiovascular interventions.4(3):273-9[DOI] 10.1161/CIRCINTERVENTIONS.110.960997.[PMID] 21521834.
31 citations·PubMed·Publisher's Site
2011
Response To Letter Regarding Article, "Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease"
Circulation: Cardiovascular Interventions.4(4):E32-[DOI] 10.1161/CIRCINTERVENTIONS.111.963959.[PMID] .
PubMed·Publisher's Site
2011
Serum Cotinine Levels Are Associated With Increased Clopidogrel-Induced Antiplatelet Effects in Patients With Diabetes Mellitus and Coronary Artery Disease
Journal of the American College of Cardiology.57():E1919-[DOI] .[PMID] .
PubMed·Publisher's Site
2011
Transradial Approach To Coronary Interventions: How Steep Is the Learning Curve for Trained Interventional Cardiologists?
Journal of the American College of Cardiology.58():B141-B142[DOI] .[PMID] .
PubMed·Publisher's Site
2010
Impact of Cangrelor On P2Y12 Mediated Platelet Reactivity in Patients With Diabetes Mellitus and Coronary Artery Disease
Cardiovascular Research.87():S96-[DOI] .[PMID] .
PubMed·Publisher's Site
2010
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
Journal of the American College of Cardiology.55(11):1139-46[DOI] 10.1016/j.jacc.2009.10.043.[PMID] 20223369.
180 citations·PubMed·Publisher's Site
2010
Impact of Staggering Clopidogrel and Omeprazole Intake On Clopidogrel-Induced Platelet Inhibition
.31():204-[DOI] .[PMID] .
PubMed·Publisher's Site
2010
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study.
Circulation. Cardiovascular interventions.3(5):436-41[DOI] 10.1161/CIRCINTERVENTIONS.110.957829.[PMID] 20858862.
46 citations·PubMed·Publisher's Site
2010
Platelet P2Y12 Receptor Signaling in Patients With Diabetes Mellitus: An in Vitro Pharmacodynamic Study
.31():173-174[DOI] .[PMID] .
PubMed·Publisher's Site
2010
Serum Cotinine Levels Are Associated With Increased Clopidogrel-Induced Antiplatelet Effects
.31():977-[DOI] .[PMID] .
PubMed·Publisher's Site
2010
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.
International journal of cardiology.145(2):235-237[DOI] 10.1016/j.ijcard.2009.08.003.[PMID] 19732979.
23 citations·PubMed·Publisher's Site
2009
Acknowledging a failed strategy.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.73(7):871-3[DOI] 10.1002/ccd.22108.[PMID] 19455650.
1 citations·PubMed·Publisher's Site
2009
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.73(1):1-14[DOI] 10.1002/ccd.21782.[PMID] 19089929.
28 citations·PubMed·Publisher's Site
2009
Clopidogrel-Induced Antiplatelet Effect Assessment By Flow Cytometry and Point-Of-Care Based Assays: Correlation Between Vasp and Verifynow P2Y(12) Testing
Journal of the American College of Cardiology.53():A71-[DOI] .[PMID] .
PubMed·Publisher's Site
2009
Evaluation of a Modified Light Transmittance Aggregometry Protocol To Assess P2Y(12) Blockade Induced By Clopidogrel
Journal of the American College of Cardiology.53():A71-[DOI] .[PMID] .
PubMed·Publisher's Site
2009
Health Care Reform Bill H. R. 3200--America's Affordable Health Choices Act: what is missing?
JACC. Cardiovascular interventions.2(10):1028-30[DOI] 10.1016/j.jcin.2009.08.013.[PMID] 19850266.
PubMed·Publisher's Site
2009
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
Thrombosis research.124(3):318-22[DOI] 10.1016/j.thromres.2008.10.001.[PMID] 19012950.
33 citations·PubMed·Publisher's Site
2009
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.73(3):291-8[DOI] 10.1002/ccd.21840.[PMID] 19214963.
19 citations·PubMed·Publisher's Site
2009
Pharmacogenetics in cardiovascular antithrombotic therapy.
Journal of the American College of Cardiology.54(12):1041-57[DOI] 10.1016/j.jacc.2009.04.084.[PMID] 19744613.
76 citations·PubMed·Publisher's Site
2009
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
Journal of the American College of Cardiology.54(17):1576-88[DOI] 10.1016/j.jacc.2009.07.021.[PMID] 19833256.
42 citations·PubMed·Publisher's Site
2009
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.73(7):890-7[DOI] 10.1002/ccd.21796.[PMID] 19455662.
5 citations·PubMed·Publisher's Site
2009
Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis.
Diabetes.58(1):209-14[DOI] 10.2337/db08-0376.[PMID] 18829988.
35 citations·PubMed·Publisher's Site
2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
European heart journal.29(18):2202-11[DOI] 10.1093/eurheartj/ehn287.[PMID] 18567918.
160 citations·PubMed·Publisher's Site
2008
A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery.
Stroke.39(2):361-5[DOI] 10.1161/STROKEAHA.107.495010.[PMID] 18174484.
42 citations·PubMed·Publisher's Site
2008
Analysis of Thrombotic Profiles in Patients With End Stage Renal Disease Undergoing Hemodialysis
Journal of Investigative Medicine.56():415-416[DOI] .[PMID] .
PubMed·Publisher's Site
2008
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
The international journal of cardiovascular imaging.24(2):125-32[DOI] .[PMID] 17541725.
7 citations·PubMed·Publisher's Site
2008
Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
The American journal of cardiology.101(6):786-9[DOI] 10.1016/j.amjcard.2007.10.045.[PMID] 18328841.
59 citations·PubMed·Publisher's Site
2008
Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus.
The international journal of cardiovascular imaging.24(4):357-64[DOI] .[PMID] 17972162.
15 citations·PubMed·Publisher's Site
2008
Clinical profile of prasugrel, a novel thienopyridine.
American heart journal.156(2 Suppl):S16-22[DOI] 10.1016/j.ahj.2008.06.005.[PMID] 18657682.
34 citations·PubMed·Publisher's Site
2008
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.72(4):448-56[DOI] 10.1002/ccd.21666.[PMID] 18814218.
48 citations·PubMed·Publisher's Site
2008
Current antiplatelet therapies: benefits and limitations.
American heart journal.156(2 Suppl):S3-9[DOI] 10.1016/j.ahj.2008.06.003.[PMID] 18657680.
43 citations·PubMed·Publisher's Site
2008
Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography.
The international journal of cardiovascular imaging.24(3):293-9[DOI] .[PMID] 17849235.
6 citations·PubMed·Publisher's Site
2008
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
The American journal of cardiology.101(4):440-5[DOI] 10.1016/j.amjcard.2007.09.087.[PMID] 18312754.
61 citations·PubMed·Publisher's Site
2008
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Thrombosis and haemostasis.99(1):161-8[DOI] 10.1160/TH07-09-0562.[PMID] 18217149.
65 citations·PubMed·Publisher's Site
2008
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
The American journal of cardiology.101(12):1704-11[DOI] 10.1016/j.amjcard.2008.02.053.[PMID] 18549844.
162 citations·PubMed·Publisher's Site
2008
Impact of the Degree of Platelet Function On Thrombin Generation Profiles in Patients With Type 2 Diabetes Mellitus
Journal of the American College of Cardiology.51():A193-[DOI] .[PMID] .
PubMed·Publisher's Site
2008
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
The American journal of cardiology.102(12):1618-23[DOI] 10.1016/j.amjcard.2008.08.021.[PMID] 19064015.
132 citations·PubMed·Publisher's Site
2008
Managing patients with intermediate in-stent restenotic lesions: is it "prime time" for intravascular ultrasound imaging?
Circulation. Cardiovascular interventions.1(2):90-2[DOI] 10.1161/CIRCINTERVENTIONS.108.817999.[PMID] 20031661.
PubMed·Publisher's Site
2008
Prasugrel: a Novel Platelet Adp P2Y(12) Receptor Antagonist. a Review On Its Mechanism of Action and Clinical Development
Expert Opinion on Pharmacotherapy.9():2893-2900[DOI] 10.1517/14656560802450405.[PMID] .
PubMed·Publisher's Site
2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development.
Expert opinion on pharmacotherapy.9(16):2893-900[DOI] 10.1517/14656566.9.16.2893.[PMID] 18937620.
36 citations·PubMed·Publisher's Site
2008
Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents.
International journal of cardiology.130(3):444-8[DOI] 10.1016/j.ijcard.2007.08.143.[PMID] 18199506.
13 citations·PubMed·Publisher's Site
2007
Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial.
American heart journal.153(2):296.e1-7[DOI] .[PMID] 17239692.
47 citations·PubMed·Publisher's Site
2007
Direct stenting in the DES era: Can we do better?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.70(4):513-4[DOI] .[PMID] 17896409.
3 citations·PubMed·Publisher's Site
2007
Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease.
American heart journal.154(2):298-305[DOI] .[PMID] 17643580.
25 citations·PubMed·Publisher's Site
2007
Heterogeneity of atherosclerotic plaque characteristics in human coronary artery disease: a three-dimensional intravascular ultrasound study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.70(3):349-56[DOI] .[PMID] 17722037.
23 citations·PubMed·Publisher's Site
2007
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Journal of the American College of Cardiology.50(16):1541-7[DOI] .[PMID] 17936152.
294 citations·PubMed·Publisher's Site
2007
Percutaneous coronary intervention of bifurcation coronary disease.
Minerva cardioangiologica.55(1):57-71[DOI] .[PMID] 17287681.
5 citations·PubMed·Publisher's Site
2007
Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: a comparative study versus standard digital angiography.
The international journal of cardiovascular imaging.23(2):225-32[DOI] .[PMID] 16871428.
9 citations·PubMed·Publisher's Site
2007
Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve.
Journal of the American College of Cardiology.50(6):514-22[DOI] .[PMID] 17678734.
105 citations·PubMed·Publisher's Site
2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
Circulation.115(6):708-16[DOI] .[PMID] 17261652.
389 citations·PubMed·Publisher's Site
2007
Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.69(2):181-8[DOI] .[PMID] 17191240.
13 citations·PubMed·Publisher's Site
2007
Stent thrombosis in the era of drug eluting stents.
Minerva cardioangiologica.55(2):199-211[DOI] .[PMID] 17342038.
8 citations·PubMed·Publisher's Site
2007
Usefulness of cardiac magnetic resonance imaging for coronary artery disease detection.
Minerva cardioangiologica.55(1):105-14[DOI] .[PMID] 17287685.
5 citations·PubMed·Publisher's Site
2007
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
Journal of the American College of Cardiology.49(14):1505-16[DOI] .[PMID] 17418288.
785 citations·PubMed·Publisher's Site
2006
"Menage a trois" or "no mas".
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.67(3):377-8[DOI] .[PMID] 16489572.
1 citations·PubMed·Publisher's Site
2006
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
Journal of the American College of Cardiology.48(6):1139-45[DOI] .[PMID] 16978996.
44 citations·PubMed·Publisher's Site
2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.
Diabetes.55(3):780-4[DOI] .[PMID] 16505243.
134 citations·PubMed·Publisher's Site
2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
Arteriosclerosis, thrombosis, and vascular biology.26(8):1895-900[DOI] .[PMID] 16645157.
181 citations·PubMed·Publisher's Site
2006
DES: technique still matters.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.67(1):10-1[DOI] .[PMID] 16345051.
PubMed·Publisher's Site
2006
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
The American journal of cardiology.97(1):38-43[DOI] .[PMID] 16377281.
99 citations·PubMed·Publisher's Site
2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
The American journal of cardiology.98(9):1182-4[DOI] .[PMID] 17056323.
11 citations·PubMed·Publisher's Site
2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
Journal of the American College of Cardiology.48(2):298-304[DOI] .[PMID] 16843179.
245 citations·PubMed·Publisher's Site
2006
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.
The American journal of cardiology.97(2):203-6[DOI] .[PMID] 16442364.
22 citations·PubMed·Publisher's Site
2006
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease.
Platelets.17(8):586-90[DOI] .[PMID] 17127487.
22 citations·PubMed·Publisher's Site
2006
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Journal of the American College of Cardiology.47(11):2172-9[DOI] .[PMID] 16750681.
77 citations·PubMed·Publisher's Site
2005
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
Thrombosis research.115(1-2):101-8[DOI] .[PMID] 15567460.
138 citations·PubMed·Publisher's Site
2005
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
Thrombosis research.116(6):491-7[DOI] .[PMID] 16181985.
116 citations·PubMed·Publisher's Site
2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
Diabetes.54(8):2430-5[DOI] .[PMID] 16046311.
425 citations·PubMed·Publisher's Site
2005
Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.
The Journal of invasive cardiology.17(8):396-8[DOI] .[PMID] 16079441.
11 citations·PubMed·Publisher's Site
2005
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
American heart journal.149(4):689-94[DOI] .[PMID] 15990754.
17 citations·PubMed·Publisher's Site
2005
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
The American journal of cardiology.96(8):1095-9[DOI] .[PMID] 16214444.
47 citations·PubMed·Publisher's Site
2004
Left main coronary artery: we are getting closer.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.61(4):482-3[DOI] .[PMID] 15065142.
PubMed·Publisher's Site
2004
Multiple plaque morphologies in a single coronary artery: insights from volumetric intravascular ultrasound.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.61(3):376-80[DOI] .[PMID] 14988899.
10 citations·PubMed·Publisher's Site
2004
Overstretching undersized drug-eluting stents: a temporary solution.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.61(4):461-2[DOI] .[PMID] 15065138.
PubMed·Publisher's Site
2004
Saphenous vein graft disease.
Minerva cardioangiologica.52(5):379-90[DOI] .[PMID] 15514573.
24 citations·PubMed·Publisher's Site
2004
Stenting small vessels? Not a small issue.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.62(4):430-1[DOI] .[PMID] 15274149.
1 citations·PubMed·Publisher's Site
2004
Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.61(3):368-75[DOI] .[PMID] 14988898.
6 citations·PubMed·Publisher's Site
2004
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
Circulation.110(4):374-9[DOI] .[PMID] 15249503.
64 citations·PubMed·Publisher's Site
2003
Brachytherapy for in-stent restenosis: the problem is one of commitment.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.59(1):6-7[DOI] .[PMID] 12720232.
PubMed·Publisher's Site
2003
Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: insights from the START trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.58(3):331-5[DOI] .[PMID] 12594697.
11 citations·PubMed·Publisher's Site
2003
Differentiation between ruptured plaque and vulnerable plaque using IVUS color flow.
International journal of cardiovascular interventions.5(4):212-[DOI] .[PMID] 14630566.
PubMed·Publisher's Site
2003
Hemodynamic complications of ventricular septal rupture after acute myocardial infarction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.60(4):509-14[DOI] .[PMID] 14624432.
4 citations·PubMed·Publisher's Site
2003
Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
International journal of radiation oncology, biology, physics.57(2):536-42[DOI] .[PMID] 12957267.
7 citations·PubMed·Publisher's Site
2002
Caught between a rock and a hard place? It is good to have some help.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.56(4):553-4[DOI] .[PMID] 12124972.
PubMed·Publisher's Site
2002
Intravascular ultrasound catheter entrapment after coronary artery stenting.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.57(2):229-33[DOI] .[PMID] 12357527.
15 citations·PubMed·Publisher's Site
2002
Mechanical thrombectomy to the RESCUE.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.55(2):244-[DOI] .[PMID] 11835657.
1 citations·PubMed·Publisher's Site
2002
Post-PCI cardiac events? The answer is the lumen, or is it in the wall?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.55(3):338-9[DOI] .[PMID] 11870938.
2 citations·PubMed·Publisher's Site
2001
Atherectomy prior to stenting bifurcation lesions: fork in the road, which direction do we choose?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.53(1):21-2[DOI] .[PMID] 11329212.
1 citations·PubMed·Publisher's Site
2001
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).
The American journal of cardiology.87(6):699-705[DOI] .[PMID] 11249886.
111 citations·PubMed·Publisher's Site
2001
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
The American journal of cardiology.87(9):1058-63[DOI] .[PMID] 11348602.
161 citations·PubMed·Publisher's Site
1997
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
The American journal of cardiology.79(3):286-91[DOI] .[PMID] 9036746.
102 citations·PubMed·Publisher's Site
1996
Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool.
Circulation.93(2):253-8[DOI] .[PMID] 8548896.
156 citations·PubMed·Publisher's Site
1995
Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II).
Circulation.92(11):3194-200[DOI] .[PMID] 7586303.
95 citations·PubMed·Publisher's Site
1995
High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions.
Journal of the American College of Cardiology.26(3):731-6[DOI] .[PMID] 7642867.
96 citations·PubMed·Publisher's Site
1994
Myocardial infarction during pregnancy: management with transluminal coronary angioplasty and metallic intracoronary stents.
American journal of obstetrics and gynecology.171(5):1392-3[DOI] .[PMID] 7977558.
20 citations·PubMed·Publisher's Site
1993
Single site experience with high-speed coronary rotational atherectomy.
Clinical cardiology.16(4):311-6[DOI] .[PMID] 8458111.
17 citations·PubMed·Publisher's Site
1992
Rotational atherectomy in anomalous coronary arteries.
Catheterization and cardiovascular diagnosis.27(4):322-4[DOI] .[PMID] 1458530.
3 citations·PubMed·Publisher's Site
1991
Clinical and angiographic determinants of primary coronary angioplasty success. M-HEART Investigators.
Journal of the American College of Cardiology.17(1):22-8[DOI] .[PMID] 1987229.
127 citations·PubMed·Publisher's Site
1991
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
American heart journal.122(5):1239-44[DOI] .[PMID] 1835276.
16 citations·PubMed·Publisher's Site
1991
Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.
Journal of the American College of Cardiology.18(3):647-56[DOI] .[PMID] 1869725.
346 citations·PubMed·Publisher's Site
1990
A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.
Circulation.81(6):1753-61[DOI] .[PMID] 2188753.
238 citations·PubMed·Publisher's Site
1990
Multi-Hospital Eastern Atlantic Restenosis Trial: design, recruitment, and feasibility. M-HEART Investigators.
Catheterization and cardiovascular diagnosis.20(4):227-37[DOI] .[PMID] 2208249.
3 citations·PubMed·Publisher's Site
1990
Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-HEART Group.
The American journal of cardiology.66(12):926-31[DOI] .[PMID] 2220614.
65 citations·PubMed·Publisher's Site
1989
Separation of afterload reduction and a direct beneficial cardiac effect of nifedipine in congestive cardiomyopathy.
Clinical cardiology.12(8):435-40[DOI] .[PMID] 2766589.
2 citations·PubMed·Publisher's Site
1987
Prolonged survival in a patient with primary angiosarcoma of the heart.
American heart journal.113(5):1228-30[DOI] .[PMID] 3578017.
18 citations·PubMed·Publisher's Site
1986
Transluminal angioplasty of anomalous coronary arteries.
American heart journal.112(3):610-3[DOI] .[PMID] 2944364.
25 citations·PubMed·Publisher's Site
1985
Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon.
Circulation.71(4):687-92[DOI] .[PMID] 3971538.
69 citations·PubMed·Publisher's Site
1985
Correlation of paradoxical atrial septal motion and an interatrial pressure gradient in severe tricuspid regurgitation.
The American journal of cardiology.55(11):1431-3[DOI] .[PMID] 3993587.
8 citations·PubMed·Publisher's Site
1985
Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
The American journal of cardiology.55(11):1359-62[DOI] .[PMID] 3993570.
35 citations·PubMed·Publisher's Site
1982
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
The American journal of cardiology.50(5):967-72[DOI] .[PMID] 6182786.
46 citations·PubMed·Publisher's Site

Office Information

Academic Office
5th Floor, Ambulatory Care Center
655 West 8th Street, C35
Jacksonville, FL 32209
(904) 244-2655
 theodore.bass@jax.ufl.edu
Administrative Manager
 Erika Jackson
(904) 244-2655
erika.jackson@jax.ufl.edu

Clinical Research

OPEN ENROLLMENT
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III)
OPEN ENROLLMENT
COBRA 2015-01 Randomized Trial of Cobra PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE)

Education

Medical Degree
1976 · The Warren Alpert Medical School of Brown University, Providence, RI, USA
Internal Medicine Residency
1979 · Mayo Graduate School of Medicine, Rochester, MN, USA
Cardiovascular Disease Fellowship
1981 · Boston University Medical Center, Boston, MA, USA

News

February 7, 2014
Bass’ passions extend beyond cardiology
December 10, 2013
Bass leads national cardiovascular society
July 19, 2013
UF Health cardiology chief leads updates for clinical competencies
August 17, 2012
Police officer grateful to doctors and others who helped save his life after heart attack
July 26, 2012
Shands Jacksonville Named a Best Regional Hospital

Media Coverage

February 3, 2015
Doctors on Call: When visiting a doctor, know before you go
Florida Times-Union

Multimedia

November 5, 2018
Cardiovascular Fellowships at the University of Florida College of Medicine – Jacksonville